Study Information
Status: Active, Recruiting
Study Details
View study details on clinicaltrials.gov.
Locations
East Bay, San Francisco
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
This is a prospective, randomized, controlled, multicenter study. Subjects will be randomized to either transcatheter aortic valve replacement (TAVR) with the SAPIEN 3 / SAPIEN 3 Ultra /SAPIEN 3 Ultra RESILIA THV or Clinical Surveillance.
Location: CPMC (San Francisco) and ABSMC (Oakland)
Please contact: Milena Ferreira ferreiml@sutterhealth.org about study Progress CAP